Rating Rationale
May 27, 2021 | Mumbai
The Oriental Insurance Company Limited
Ratings Reaffirmed
 
Rating Action
Rs.750 Crore Subordinated DebtCRISIL AAA/Stable (Reaffirmed)
Corporate Credit RatingCCR AAA/Stable (Reaffirmed)
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL has reaffirmed its Corporate Credit Rating (CCR) and rating on subordinated debt issue of The Oriental Insurance Company Limited (Oriental Insurance) at 'CCR AAA/Stable’ and ‘CRISIL AAA/Stable', respectively.

 

The rating on the hybrid instrument remains centrally based on forbearance granted by Insurance Regulatory and Development Authority of India (IRDAI) to Oriental Insurance from adhering to provisions 3(vii) and 5(vii) of Insurance Regulatory and Development Authority of India (Other Forms of Capital) Regulations, 2015, for this specific subordinated debt issue of Rs 750 crore. The forbearance allows the company to service the interest or coupon payments to the investors in the issue throughout the life of the instrument, irrespective of solvency ratio. IRDAI has also granted forbearance against provision 14 of the regulation and has allowed the company to issue subordinated debt to the extent of 25% of its networth as on September 30, 2018.

 

The ratings reflect the company's strategic importance to, and expectation of strong support from, the Government of India (GoI), in addition to its established market position in the Indian general insurance industry. These strengths are partially offset by the low cushion in solvency ratio and capitalization remaining dependent on equity infusion by the government. The company’s underwriting performance remains modest, imposing pressure on overall profitability and solvency.

 

With a track record of over 60 years, Oriental ranked as the sixth largest insurer in the industry based on the gross premiums written during fiscal 2021 with a market share of 6.3%. As macro growth prospects remained subdued after the outbreak of Covid-19, the company’s gross direct premium de-grew by 8.9% over fiscal 2021, as against the industrial growth of 5.2% for the same period. 

 

During the year, the company honoured Rs 609.4 crore of claims as coverage for Covid-19 cases. Apart from the standard product – Corona Kavach, these claims were also reported from the traditional medi-claim policyholders. However, claims for non-Covid illnesses/ casualties were lower during the year. Similarly, for other segments also – instances of claim reports were lower this year attributed to restricted public activity and vehicular traffic. This led to a reduced claims ratio of 93.3% for the first nine months of fiscal 2021 as compared to 105.3% for the corresponding period of the previous fiscal. Resultantly, combined ratio of the company also improved to 129.6% from 137.3% over the same period.

 

With onset of the second wave, as the severity and frequency of casualties is higher and penetration of health insurance has increased in the last 1 year, an upward revision in Covid-19 coverage products could be in order so as to adequately factor in the increased risks. In the near to medium term, the losses incurred from Covid 19 and its impact on the company’s overall underwriting performance remains a key monitorable.

 

The company's reported networth stood at Rs 2,201 crore on December 31, 2020, which, in addition to the balance in fair value change account, further increases to Rs 6,405 crore. Since Q4 2020, the company has received Rs 3,220 crore as equity capital from the government of India. This has added some cushion to the networth. Reported solvency, including 85% of the balance in fair value change account, stood at 1.53 times on December 31, 2020 and 1.55 times as on March 31, 2020.

 
While networth has increased after equity infusion by the government and revival in the fair value change balance after Q4 2020, the company's ability to accelerate the improvement in underwriting performance so as to self-sustain capital position in solvency remains critical in the medium to long run.

 
For nine months ended December 31, 2020, the company reported an underwriting deficit of Rs 2366 crore, which led to an overall loss of Rs 758 crore for the period. This modesty in earnings profile was partly offset by Rs 1737 crore of investment income earned during the first nine months of fiscal 2021.

 

For fiscal 2022, the growth in new business premium for larger segments like motor insurance could remain muted for a longer stretch as revival in new sales volumes in the auto sector will happen only at a gradual pace once the lockdowns across states are lifted. Renewal premiums from the retail segment could also been impacted on account of job losses and pay-cuts. For the health segment - which is the second largest after motor, growth prospects will remain strong driven by increased market awareness and demand for multiple covers. In a scenario where pricing for Covid-19 policies is revised upwards, growth in this segment could be higher than that of last fiscal. However, with increasing ticket size of Covid-19 claims, the impact of actual losses borne by the insurers after the second wave – on their underwriting performance and capital and solvency position, remains to be seen.

Analytical Approach

CRISIL has first arrived at Oriental Insurance's corporate credit rating, which is an indication of the company's ability to honour its debt obligations and policyholders' obligations. For arriving at the CCR, CRISIL has factored in expectation of strong government support, in addition to the assessment of business, financial, and management risk profiles of the company. The subordinated debt instrument is then tested for additional risk factors to determine whether its rating should be the same as, or lower than the CCR. The extent of cushion that Oriental Insurance intends to maintain in the solvency ratio over and above the regulatory stipulation on a steady state basis is taken into consideration to arrive at the rating on the subordinated debt instrument.

 
In the case of Oriental Insurance, the regulatory forbearance granted to the company virtually eliminates the risk factor for its subordinated debt issue as it is allowed to service the interest or coupon payments throughout the life of the instrument irrespective of the solvency ratio.

Key Rating Drivers & Detailed Description

Strengths:

  • Support from, and strategic importance to, the Government of India (GoI)

Oriental is expected to receive strong support from the government on a steady state basis, driven by its established market position in the Indian non-life insurance sector, which makes it strategically very important to the Government. The importance of the general insurance sector, especially government-owned insurers, can also be perceived in the context of GoI's plan to materially enhance insurance penetration over the long term. As a demonstration of their strategic importance to GOI and the latter’s stance on extending timely support, public general insurers were allotted Rs 12,450 crore of capital by the GoI in July 2020 (including Rs 2500 crore which had already been infused in March 2020). Oriental, National Insurance Company Ltd (National) and The United India Insurance Company Ltd (United) cumulatively received Rs 2500 crore in fiscal 2020 and Rs 9,950 crore in fiscal 2021. Of this allocation, Oriental received Rs 50 crore in fiscal 2020 and Rs 3,170 crore in fiscal 2021.


Along with the capital allocation, the government also announced its decision of shelving the merger process of Oriental with National and United, and focusing on improving the standalone financial risk profiles of these entities. CRISIL also takes note of the government’s plan announced in the last annual budget – to privatise one of the public general insurers in the medium to long term, and would continue to monitor the developments in this aspect.

 

  • Established market position with long track record and extensive market reach

Oriental Insurance, with a market share of 6.3% for fiscal 2021, is the sixth largest player in the Indian general insurance space with over 1670 branches across the country. More so, its status of being a GoI promoted entity would enable it to sustain competitive edge amidst intensifying competition.

 

The company underwrote a gross direct premium of Rs 12,452 crore during the year, which marks a decline of 8.9% over the business that it wrote in the last fiscal. This reduction primarily stemmed from negative growth in key segments like motor and crop – which is applicable for the entire sector. Over fiscal 2021, the general insurance sector witnessed a negative growth of 1.7% in the motor segment and of 3.4% in the crop segment. Against this, Oriental’s motor premium de-grew by 10.8% whereas premium from the crop segment de-grew by 61.1%. In the health segment, wherein the industry grew at a healthy 13.4% during fiscal 2021 driven by increased demand for products offering Covid-19 coverage, Oriental adapted a cautious approach in light of limited performance track record of Covid-19 products, and grew at 2.2% only. During fiscal 2021, ~6.3% of the total premium written within the health segment was contributed by Covid-19 products launched during the year.

 

Some impact of this calibrated growth strategy was offset by a healthy growth of 23.8% that Oriental witnessed in the fire segment – which was in line with the trend observed for the industry. This was stimulated by standardisation of rates across players.

 

Over the near to medium term, the company plans to grow at 5-10% with the underlying premise that the second wave of the pandemic should tail out by the end of Q1 2022. This growth will be driven by motor, health and fire segments. Oriental also plans to run down its loss making crop portfolio to ~10% of the total premium base.

 

Weaknesses:

  • Reported solvency remains below regulatory stipulation, capitalisation is dependent on equity infusion by GoI

Capitalisation and solvency position of Oriental Insurance remains strained. On March 31, 2020, the company reported a solvency ratio of 0.92 times (factoring in 100% of the balance in fair value change account as on that date) as against 1.57 times reported on March 31, 2019 (factoring in 40% of the balance in fair value change account as on that date). This sharp decline was attributed to the reduction in fair value change balance imposed by volatility in equity markets, from Rs 7,586 crore to Rs 2261 crore over the same period. Thereafter, driven by capital infusion by the government and gradual recovery in equity markets, Oriental’s solvency ratio (factoring in 85% of the balance in fair value change account as on that date) recovered to 1.53 times and 1.55 times (provisional)  as of December 31, 2020 and March 31, 2021 respectively. As a result of this capital infusion, the company’s reported networth also increased from Rs 1389 crore (not adjusted for miscellaneous expenditure of Rs 1188 crore) as on March 31, 2020 to ~Rs 3000 crore (provisional) as of March 31, 2021.

 

Over the medium term, Oriental’s capitalisation and solvency position are expected to remain dependent on equity support from the government and the company’s fair value change balance. Additional comfort is drawn from regulatory relaxations allowed by the government to the company, in terms of including fair value change balance in its solvency reporting. The company aims to restore its solvency position to 1.5 times (excluding fair value change balance) by the end of fiscal 2022. In the meantime, continued weakness in underwriting and overall profitability leading to further moderation in capital and solvency position of the company, will remain key rating sensitivity factors.

 

  • Weak underwriting performance

Oriental’s underwriting performance remains weak. After recognition of additional reserving requirement in motor third party business in fiscal 2017, the company’s underwriting performance has remained volatile. After the loss reported in fiscal 2017, the company’s underwriting performance had improved momentarily in fiscal 2018. However, it has remained weak since then. For fiscal 2020, the company reported an underwriting deficit of Rs 4,515 crore, which was higher than Rs 3,771 crore of deficit reported for the previous fiscal. Correspondingly, the combined ratio also increased to 141.1% from 134.9% over this period driven by a rise in expense ratio from 28.8% to 38.8%. However, some of this moderation was offset by the improvement in claims ratio from 106.1% to 102.3%.

 

For nine months ended December 31, 2020, the company’s underwriting deficit stood at Rs 2366 crore – marginally lower than a deficit of Rs 2943 crore reported for the corresponding nine months of last fiscal. Combined ratio for the first nine months of fiscal 2021, at 129.6%, was lower than 137.3% exhibited for the corresponding nine months of the previous fiscal – driven by reduced instances of claims during the first half of fiscal 2021 due to the lockdown. While claims ratio for fiscal 2021 is not expected to increase materially from current levels, with restoration in operational activity – specially increased vehicular activity on the roads – claims would increase to its pre-covid levels.

 

Oriental’s underwriting performance is expected to remain modest over the medium term and improve only gradually in the long term. In the first nine months of fiscal 2021, of the total claims incurred by the company - ~15% were contributed by Covid-19 losses. However, with increased penetration of health insurance products over the last 3-4 quarters alongside surge in Covid-19 casualties, losses from Covid-19 are expected to have risen sharply over the first few months of fiscal 2022. However, similar to the last fiscal – its impact on the overall claims ratio would be net off by reduction in other, regular claims across motor, fire and other segments.

 

Any further deterioration in the company’s underwriting performance, straining its earnings profile and capitalisation further, will be a key rating sensitivity factor.

 

  • Modest earnings profile

Oriental's earnings profile has remained modest because of its weak underwriting performance. Despite a stable investment income of Rs 3475 crore for fiscal 2020, the company reported a net loss of Rs 1524 crore for the year as against a loss of Rs 294 crore for fiscal 2019. This deterioration was a factor of increased underwriting deficit for fiscal 2020.

 

For nine months ended December 31, 2020, while the underwriting deficit did not increase materially from that of the corresponding nine months of fiscal 2020, income from investments declined sharply owing to volatility in the markets. For 9M 2021, Oriental earned Rs 1737 crore as income from investments as compared to Rs 2,477 crore earned for the corresponding previous period. With underwriting loss remaining almost flat at Rs 2,366 crore, net loss for nine months ended December 31, 2021 was Rs 758 crore as against Rs 388 crore for the first nine months of fiscal 2020.

 

Going forward, the company's ability to accelerate improvement in underwriting performance such that overall profitability is revived and, capital position and solvency is sustained at strong levels, will remain a key monitorable.

Liquidity: Superior

Liquidity position of Oriental Insurance remains comfortable, supported by adequate investments being parked in highly liquid ' Government securities. On December 31, 2020, such investments formed 57% of the investment portfolio with a larger share being parked in state government bonds. Liquid assets amounted to over Rs 14,000 crore on March 31, 2020 ' largely parked in G-Secs and as cash. Additionally, the company typically maintains a cash and bank balance of over Rs. 2,000 crore. The company also benefits from a large balance of un-booked appreciation from equity investments and an extensive base of fixed assets which can be dipped into if need be.

Outlook: Stable

Oriental Insurance should maintain its competitive position in the Indian general insurance industry, alongside sustaining its sound portfolio quality, adequate capitalisation, and will receive support from GoI in the unlikely event of financial distress. The rating on the subordinated debt instrument also factors in the regulatory forbearance granted to Oriental Insurance.

Rating Sensitivity factors

Downward factors

  • Lack of improvement in underwriting performance within the expected timeline, leading to an adverse impact on overall profitability and solvency margin (excluding balance in fair value change account) remaining below 1.5 times for a prolonged period of time.
  • A sizeable reduction in the extent of ownership or strategic importance, to Government of India.

About the Company

Oriental Insurance is India’s sixth-largest non-life insurance company. Set up in Mumbai in 1947, the company commenced its operations as a wholly owned subsidiary of Oriental Government Security Life Assurance Company Ltd. It was a subsidiary of Life Insurance Corporation of India (LIC) from 1956 to 1973. Oriental Insurance, with its head office in New Delhi, has an extensive network of 1676 branches across the country. The company also has operations in Nepal, Kuwait, and Dubai.

Key Financial Indicators

As on/For the period ended March 31

Unit

2020

2019

2018

Gross direct premium/Gross premium written

Rs crore

13,996

13,485

10,028

Profit/(loss) after tax

Rs crore

(1524)

(294)

1,510

Combined ratio

%

141.1

134.9

118.6

Solvency margin

Times

0.92^

1.57*

1.67

Adjusted solvency margin^

Times

0.92

2.79

4.89

*includes 40% of balance in fair value change account

^includes 100% of balance in fair value change account

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of Instrument

Date of Allotment

Coupon Rate (%)

Maturity Date

Issue Size
(Rs cr)

Complexity Level

Rating Assigned with Outlook

INE06GZ08015

Subordinated Debt^

18-Mar-19

8.80%

18-Mar-29

750

Complex

CRISIL AAA/Stable

^call option after 5 years of issuance

Annexure - Rating History for last 3 Years
  Current 2021 (History) 2020  2019  2018  Start of 2018
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Corporate Credit Rating LT 0.0 CCR AAA/Stable   -- 29-05-20 CCR AAA/Stable   --   -- --
Subordinated Debt LT 750.0 CRISIL AAA/Stable   -- 29-05-20 CRISIL AAA/Stable 26-02-19 CRISIL AAA/Stable   -- --
      --   -- 24-02-20 CRISIL AAA/Stable   --   -- --
Financial Strength rating LT   --   -- 29-05-20 Withdrawn 26-02-19 CRISIL AAA/Stable 31-05-18 CRISIL AAA/Stable CRISIL AAA/Stable
      --   -- 24-02-20 CRISIL AAA/Stable   --   -- --
All amounts are in Rs.Cr.
 
 

               

Criteria Details
Links to related criteria
Rating Criteria for General Insurance Companies
Criteria for Notching up Stand Alone Ratings of Entities Based on Government Support

Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
 naireen.ahmed@crisil.com

Krishnan Sitaraman
Senior Director and Deputy Chief Ratings Officer
CRISIL Ratings Limited
D:+91 22 3342 8070
krishnan.sitaraman@crisil.com


Ajit Velonie
Director
CRISIL Ratings Limited
D:+91 22 4097 8209
ajit.velonie@crisil.com


Vani Ojasvi
Manager
CRISIL Ratings Limited
D:+91 22 6172 3560
Vani.Ojasvi@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Ratings Limited

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ("CRISIL Ratings") is a wholly-owned subsidiary of CRISIL Limited ("CRISIL"). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisil.com/ratings 




About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale (each a "Report") that is provided by CRISIL Ratings Limited  (hereinafter referred to as "CRISIL Ratings") . For the avoidance of doubt, the term "Report" includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. Rating by CRISIL Ratings contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way. CRISIL Ratings or its associates may have other commercial transactions with the company/entity.

Neither CRISIL Ratings nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, "CRISIL Ratings Parties") guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Ratings Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL RATINGS' PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL Rating's public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: http://www.crisil.com/ratings/highlightedpolicy.html

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL Ratings you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings Limited is a wholly owned subsidiary of CRISIL Limited.

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011 to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratiings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: www.crisil.com/ratings/credit-rating-scale.html